Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers

NCT00095862 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: allogeneic GM-CSF-secreting breast cancer vaccine
BIOLOGICAL: recombinant interferon alfa
DRUG: cyclophosphamide

Sponsor

Wiseman Research Initiatives LLC